|
The Deposition
The
following transcript excerpts are from a session of the pretrial
deposition of Jeffrey Wigand, former vice president of research and
development for the Brown & Williamson Tobacco Corporation.
The November 29, 1995,
testimony was given in a lawsuit brought by the State of Mississippi
seeking reimbursement for the cost of treating smoking-related
illnesses. In this deposition, Ronald Motley was the attorney
for the State of Mississippi, Tom Bezanson was representing Brown
& Williamson and Jeffrey Wigand was a key witness in the case.
(According to the transcript, obvious typographical errors are
corrected in brackets. Note: BAT is British American Tobacco,
NT is National Toxicology, NTP is National Toxicology Program and
STP is Smokeless Tobacco Products.)
WIGAND IS ASKED BY MOTLEY ABOUT HOW HE
WAS HIRED BY BROWN & WILLIAMSON
MOTLEY QUESTIONS WIGAND ABOUT HIS JOB
RESPONSIBILITIES AT BROWN & WILLIAMSON
MOTLEY INQUIRES ABOUT LAWYER
INVOLVEMENT IN RESEARCH AT BROWN &
WILLIAMSON
WIGAND IS ASKED BY MOTLEY ABOUT A
MEETING OF BAT SCIENTISTS IN VANCOUVER, BRITISH
COLUMBIA
WIGAND IS ASKED ABOUT MINUTES TAKEN
DURING THAT MEETING
WIGAND IS ASKED IF HE BELIEVED THAT THE
PRESIDENT OF BROWN & WILLIAMSON FELT THAT NICOTINE WAS
ADDICTIVE
MOTLEY ASKS ABOUT SANDEFUR’S
INVOLVEMENT IN THE DEVELOPMENT OF A “SAFER
CIGARETTE”
WIGAND IS ASKED ABOUT WHETHER RESEARCH
CONDUCTED ON NICOTINE PRIOR TO HIS ARRIVAL WAS DISCLOSED TO
HIM
MOTLEY QUESTIONS WIGAND ON WHETHER
LAWYERS ALTERED SCIENTIFIC RESEARCH
WIGAND IS ASKED ABOUT THE INVOLVEMENT
OF BROWN & WILLIAMSON LAWYERS IN RESEARCH
WIGAND IS ASKED ABOUT SUPPRESSION OF
RESEARCH FINDINGS
WIGAND IS ASKED WHETHER BROWN &
WILLIAMSON USED RAT POISON IN PIPE TOBACCO
WIGAND IS ASKED ABOUT WHERE HE THOUGHT
BROWN & WILLIAMSON STOOD ON THE ISSUE OF “SAFER
CIGARETTES”
MOTLEY ASKS WIGAND ABOUT WHETHER HE
KEPT RECORDS OF EVENTS AT BROWN &
WILLIAMSON
WIGAND IS ASKED ABOUT WHY HE KEPT THE
RECORDS
WIGAND IS ASKED ABOUT BROWN &
WILLIAMSON LAWYERS SENDING DOCUMENTS TO
ENGLAND
MOTLEY ASKS WIGAND ABOUT NICOTINE
PHARMACOLOGY
WIGAND DESCRIBES HOW SMOKERS ARE
“MAINTAINED”
MOTLEY ASKS WIGAND IF BROWN &
WILLIAMSON EVER MANIPULATED NICOTINE LEVELS IN TOBACCO
PRODUCTS
WIGAND DESCRIBES HOW LEVELS OF NICOTINE
ARE MANIPULATED
WIGAND ANSWERS QUESTIONS ABOUT Y-1
BLENDING - A PROCESS TO REDUCE TAR IN TOBACCO
MOTLEY ASKS ABOUT THE PREVALENCE OF
NICOTINE MANIPULATION IN THE INDUSTRY
MOTLEY QUESTIONS WIGAND ABOUT THE USE
OF AMMONIA TECHNOLOGY IN TOBACCO PRODUCTS
WIGAND IS QUESTIONED ABOUT THE EFFECT
OF NICOTINE ON THE BODY
MOTLEY ASKS WIGAND ABOUT OTHER
CIGARETTE ADDITIVES
MOTLEY QUESTIONS WIGAND ABOUT THE
ADDICTIVENESS OF NICOTINE
WIGAND IS QUESTIONED ABOUT THREATS MADE
TO HIM
MOTLEY ASKS WIGAND ABOUT THREATS MADE
TO HIS FAMILY
WIGAND IS ASKED ABOUT A 1963 BROWN
& WILLIAMSON DOCUMENT THAT SAYS THAT NICOTINE IS AN ADDICTIVE
DRUG
|
